{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T21:01:19Z","timestamp":1780261279553,"version":"3.54.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ajur.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:10:07Z","timestamp":1773130207000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating the tension between missed diagnosis and overdiagnosis: A comparison of the recent Chinese Urological Association and European Association of Urology guidelines on prostate biopsy"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-8372","authenticated-orcid":false,"given":"Jin","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2026.02.001_bib1","author":"Cornford"},{"key":"10.1016\/j.ajur.2026.02.001_bib2","series-title":"Chinese guidelines for diagnosis and treatment of urological and male reproductive diseases","author":"Huang","year":"2024"},{"key":"10.1016\/j.ajur.2026.02.001_bib3","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajur.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2004.11.007","article-title":"Incidence of prostate cancer in Sicily: results of a multicenter case-findings protocol","volume":"47","author":"Aragona","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib5","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.ajur.2026.02.001_bib6","first-page":"801","article-title":"[Chinese expert consensus on prostate biopsy (2022 edition)]","volume":"43","year":"2022","journal-title":"Chin J Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.juro.2016.08.103","article-title":"Prostate specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies compared with Western cohorts","volume":"197","author":"Chen","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067585","article-title":"Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population","volume":"8","author":"Na","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajur.2026.02.001_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/pcan.2010.29","article-title":"Incidence of insignificant prostate cancer using free\/total PSA: results of a case-finding protocol on 14 453 patients","volume":"13","author":"Pepe","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ajur.2026.02.001_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2017.01.033","article-title":"Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer risk calculator for initial prostate biopsy by incorporating the 2014 International Society of Urological Pathology Gleason grading and cribriform growth","volume":"72","author":"Roobol","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100305","article-title":"Blood and urine-based biomarkers in prostate cancer: current advances, clinical applications, and future directions","volume":"9","author":"Crocetto","year":"2025","journal-title":"J Liq Biopsy"},{"key":"10.1016\/j.ajur.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.eururo.2014.08.010","article-title":"Comparison between the four-kallikrein panel and Prostate Health Index for predicting prostate cancer","volume":"68","author":"Nordstr\u00f6m","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.04.012","article-title":"Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score","volume":"70","author":"Van Neste","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajur.2026.02.001_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12491","article-title":"UPCARE: urinary extracellular vesicles-derived prostate cancer assessment for risk evaluation","volume":"13","author":"Jiang","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ajur.2026.02.001_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouviere","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajur.2026.02.001_bib17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajur.2026.02.001_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2214\/AJR.18.20103","article-title":"Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"212","author":"Kang","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ajur.2026.02.001_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"Van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euf.2020.10.007","article-title":"Intraductal carcinoma of the prostate: pathogenesis and molecular perspectives","volume":"7","author":"Zong","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ajur.2026.02.001_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajur.2026.02.001_bib23","article-title":"68Ga-PSMA PET\/CT evaluation in men enrolled in prostate cancer Active Surveillance","volume":"95","author":"Pepe","year":"2023","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.ajur.2026.02.001_bib24","article-title":"BRCA mutations and prostate cancer: should urologist improve daily clinical practice?","volume":"97","author":"Vatrano","year":"2025","journal-title":"Arch Ital Urol Androl"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388226000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388226000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T20:10:14Z","timestamp":1780258214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388226000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2214388226000196"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2026.02.001","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the tension between missed diagnosis and overdiagnosis: A comparison of the recent Chinese Urological Association and European Association of Urology guidelines on prostate biopsy","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Editorial Office of Asian Journal of Urology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}